Sintx Technologies, Inc.

NasdaqCM SINT

Sintx Technologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD -11.63 M

Sintx Technologies, Inc. EBIT is USD -11.63 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -17.66% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Sintx Technologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -9.89 M, a -2.25% change year over year.
Sintx Technologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -9.67 M, a -8.59% change year over year.
Sintx Technologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -8.91 M, a -36.01% change year over year.
Sintx Technologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -6.55 M, a -28.92% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NasdaqCM: SINT

Sintx Technologies, Inc.

CEO	Mr. Eric K. Olson
IPO Date	Feb. 13, 2014
Location	United States
Headquarters	1885 West 2100 South
Employees	43
Sector	Materials
Industries Chemicals & Advanced Materials Pharmaceuticals Semiconductors

Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Key trends

Past 5 years